Showing codes 44183-890-31 Desvenlafaxine — 44224-0007-1 Afterbite With Antihistimine

44183-890-31 - Desvenlafaxine
Firm: Macoven Pharmaceuticals
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (44183-890-31)
Usage type: ORAL
HTML  TXT

44183-890-90 - Desvenlafaxine
Firm: Macoven Pharmaceuticals
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (44183-890-90)
Usage type: ORAL
HTML  TXT

44183-900-04 - Spinosad
Firm: Macoven Pharmaceuticals
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (44183-900-04) > 120 mL in 1 BOTTLE, PLASTIC
Usage type: TOPICAL
HTML  TXT

44206-251-05 - Alburx
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-251-05) > 50 mL in 1 VIAL, GLASS (44206-251-90)
Usage type: INTRAVENOUS
HTML  TXT

44206-251-10 - Alburx
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-251-10) > 100 mL in 1 VIAL, GLASS (44206-251-91)
Usage type: INTRAVENOUS
HTML  TXT

44206-300-01 - Rhophylac
Firm: CSL Behring AG
Package Description: 1 SYRINGE, GLASS in 1 CARTON (44206-300-01) > 2 mL in 1 SYRINGE, GLASS (44206-300-90)
Usage type: INTRAMUSCULAR; INTRAVENOUS
HTML  TXT

44206-300-10 - Rhophylac
Firm: CSL Behring AG
Package Description: 10 SYRINGE, GLASS in 1 CARTON (44206-300-10) > 2 mL in 1 SYRINGE, GLASS (44206-300-90)
Usage type: INTRAMUSCULAR; INTRAVENOUS
HTML  TXT

44206-310-25 - Alburx
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-310-25) > 250 mL in 1 VIAL, GLASS (44206-310-90)
Usage type: INTRAVENOUS
HTML  TXT

44206-310-50 - Alburx
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-310-50) > 500 mL in 1 VIAL, GLASS (44206-310-91)
Usage type: INTRAVENOUS
HTML  TXT

44206-416-03 - Carimune
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (44206-416-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-416-90)
Usage type: INTRAVENOUS
HTML  TXT

44206-417-06 - Carimune
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (44206-417-06) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-417-91)
Usage type: INTRAVENOUS
HTML  TXT

44206-418-12 - Carimune
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (44206-418-12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-418-92)
Usage type: INTRAVENOUS
HTML  TXT

44206-436-05 - Privigen
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-436-05) > 50 mL in 1 VIAL, GLASS (44206-436-90)
Usage type: INTRAVENOUS
HTML  TXT

44206-437-10 - Privigen
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-437-10) > 100 mL in 1 VIAL, GLASS (44206-437-91)
Usage type: INTRAVENOUS
HTML  TXT

44206-438-20 - Privigen
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-438-20) > 200 mL in 1 VIAL, GLASS (44206-438-92)
Usage type: INTRAVENOUS
HTML  TXT

44206-439-40 - Privigen
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-439-40) > 400 mL in 1 VIAL, GLASS (44206-439-93)
Usage type: INTRAVENOUS
HTML  TXT

44206-451-01 - Hizentra
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-451-01) / 5 mL in 1 VIAL, SINGLE-DOSE (44206-451-90)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-452-02 - Hizentra
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-452-02) / 10 mL in 1 VIAL, SINGLE-DOSE (44206-452-91)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-454-04 - Hizentra
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-454-04) / 20 mL in 1 VIAL, SINGLE-DOSE (44206-454-92)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-455-10 - Hizentra
Firm: CSL Behring AG
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (44206-455-10) / 50 mL in 1 VIAL, SINGLE-DOSE (44206-455-93)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-455-25 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-455-25) / 50 mL in 1 SYRINGE (44206-455-97)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-456-21 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-456-21) / 5 mL in 1 SYRINGE (44206-456-94)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-456-94 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-456-94) > 5 mL in 1 SYRINGE (44206-456-21)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-457-22 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-457-22) / 10 mL in 1 SYRINGE (44206-457-95)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-457-95 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-457-95) > 10 mL in 1 SYRINGE (44206-457-22)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-458-24 - Hizentra
Firm: CSL Behring AG
Package Description: 1 SYRINGE in 1 CARTON (44206-458-24) / 20 mL in 1 SYRINGE (44206-458-96)
Usage type: SUBCUTANEOUS
HTML  TXT

44206-532-11 - Cytogam
Firm: CSL Behring AG
Package Description: 1 VIAL, GLASS in 1 CARTON (44206-532-11) / 50 mL in 1 VIAL, GLASS (44206-532-90)
Usage type: INTRAVENOUS
HTML  TXT

44224-0002-1 - After Bite The Itch Eraser Xtra
Firm: Tender Corporation
Package Description: 1 TUBE in 1 BOX (44224-0002-1) > 20 g in 1 TUBE
Usage type: TOPICAL
HTML  TXT

44224-0005-3 - After Bite The Itch Eraser Kids
Firm: Tender Corporation
Package Description: 1 TUBE in 1 BOX (44224-0005-3) > 20 g in 1 TUBE
Usage type: TOPICAL
HTML  TXT

44224-0006-1 - Afterburn
Firm: Tender Corporation
Package Description: 1 TUBE in 1 BOX (44224-0006-1) > 57 g in 1 TUBE
Usage type: TOPICAL
HTML  TXT

44224-0007-1 - Afterbite With Antihistimine
Firm: Tender Corporation
Package Description: 1 TUBE in 1 BOX (44224-0007-1) > 20 mL in 1 TUBE
Usage type: TOPICAL
HTML  TXT